Transgender hormone therapy (female-to-male) to individuals taking bioidentical hormones in the form of testosterone (including esters) and do not apply to those taking synthetic AAS (e.g., nandrolone) or dihydrotestosterone. Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people
Fraternal birth order and male sexual orientation studies have demonstrated that the fraternal birth order effect does not operate through social or postnatal (e.g., learning or rearing or environmental) mechanisms; rather it is biological in nature and operates prenatally. It is also known that the fraternal birth order effect on male sexual orientation is unaffected by family dynamics, living with older brothers or learning. Fraternal birth order and male sexual orientation A correlation between fraternal birth order and male sexual orientation has been suggested by research. Ray Blanchard identified the association and referred to it as the fraternal birth order effect. In several studies, the observation is